Autres langues Lee's Pharmaceutical Holdings Limited

Actions

950 KYG5438W1116

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:17 07/05/2024			Varia. 5j.	Varia. 1 janv.
1,18 ^HKD	0,00 %		+6,31 %	-22,88 %

19/04	Le bénéfice de Lee's Pharmaceutical pour l'année 2023 chute de 67%.	MT
26/03	Lee's Pharmaceutical Holdings Limited propose un dividende final ordinaire pour l'exercice clos le 31 décembre 2023, payable le 17 juin 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lee’s Pharmaceutical's 2023 Profit Slumps 67%	19/04
Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	26/03
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
China Grants Lee's Pharmaceutical Drug Registration for Schizophrenia-Related Agitation Treatment; Shares Rise 3%	29/11
Lee’s Pharmaceutical Sells Rights for Eyprotor to Zhaoke Ophthalmology for 60 Million Yuan	14/11
Lee's Pharmaceutical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 October 2023	30/08/23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Lee's Pharmaceutical Holdings Unit's Fentanyl Inhalable Reaches Endpoints in Phase 2A Trial	22/08/23
Lee's Pharmaceutical Holdings Limited Announces Phase IIa Clinical Trial of A F fentanyl Aerosol for Inhalation Conducted by Zhaoke Pharmaceutical Limited	21/08/23
Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	21/08/23
Lee’s Pharmaceutical Gets Registration Certificate for Medical Device to Treat Hypoxic Respiratory Failure	09/06/23
Lee's Pharmaceutical Holdings Limited Appoints Cheang Yee Wah, Eva as Independent Non-Executive Director	17/05/23
Lee's Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 15 June 2023	30/03/23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Lee’s Pharmaceutical Holdings Warns of Plunge in 2022 Profit	21/03/23
Lee's Pharmaceutical Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	20/03/23
Extended Phase 2b Study for Lee's Pharmaceutical's Tafoxiparin Concludes; Shares Slip 3%	17/02/23
Nine Lee's Pharma Products Included in China's National Reimbursement Drug List	20/01/23
Lee's Pharmaceutical Holdings Limited Announces Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List	19/01/23
Lee's Pharmaceutical's Q3 Profit More Than Doubles	24/11/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Lee's Pharmaceutical Holdings Limited

Actions

950

KYG5438W1116

Autres langues

Filtres